AI Verdict
GMED has stronger fundamentals based on our AI analysis.
GMED vs GLXZ Fundamental Comparison
| Metric | GMED | GLXZ |
|---|---|---|
| Revenue | $2.9B | $30.9M |
| Net Income | $537.9M | $1.5M |
| Net Margin | 18.3% | 4.8% |
| ROE | 11.8% | N/A |
| ROA | 10.1% | 5.4% |
| Current Ratio | 4.26x | 1.44x |
| Debt/Equity | 0.00x | N/A |
| EPS | $3.92 | $0.06 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GMED vs GLXZ: Frequently Asked Questions
Is GMED or GLXZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GMED has stronger fundamentals. GMED is rated BUY (78% confidence) while GLXZ is rated SELL (72% confidence). This is not investment advice.
How does GMED compare to GLXZ fundamentally?
GLOBUS MEDICAL INC has ROE of 11.8% vs Galaxy Gaming, Inc.'s N/A. Net margins are 18.3% vs 4.8% respectively.
Which stock pays higher dividends, GMED or GLXZ?
GMED has a dividend yield of N/A or no dividend while GLXZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GMED or GLXZ for long term?
For long-term investing, consider that GMED has BUY rating with 78% confidence, while GLXZ has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GMED vs GLXZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GMED vs GLXZ, the AI consensus favors GMED based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.